189 related articles for article (PubMed ID: 36794636)
1. Pathways linking aging and atheroprotection in Mif-deficient atherosclerotic mice.
Krammer C; Yang B; Reichl S; Besson-Girard S; Ji H; Bolini V; Schulte C; Noels H; Schlepckow K; Jocher G; Werner G; Willem M; El Bounkari O; Kapurniotu A; Gokce O; Weber C; Mohanta S; Bernhagen J
FASEB J; 2023 Mar; 37(3):e22752. PubMed ID: 36794636
[TBL] [Abstract][Full Text] [Related]
2. Mif-deficiency favors an atheroprotective autoantibody phenotype in atherosclerosis.
Schmitz C; Noels H; El Bounkari O; Straussfeld E; Megens RTA; Sternkopf M; Alampour-Rajabi S; Krammer C; Tilstam PV; Gerdes N; Bürger C; Kapurniotu A; Bucala R; Jankowski J; Weber C; Bernhagen J
FASEB J; 2018 Aug; 32(8):4428-4443. PubMed ID: 29543531
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of atherosclerotic lesions in diabetic apolipoprotein E-deficient mice using gene silencing of macrophage migration inhibitory factor.
Sun H; Zhang X; Zhao L; Zhen X; Huang S; Wang S; He H; Liu Z; Xu N; Yang F; Qu Z; Ma Z; Zhang C; Zhang Y; Hu Q
J Cell Mol Med; 2015 Apr; 19(4):836-49. PubMed ID: 25661015
[TBL] [Abstract][Full Text] [Related]
4. Deficiency in lymphotoxin β receptor protects from atherosclerosis in apoE-deficient mice.
Grandoch M; Feldmann K; Göthert JR; Dick LS; Homann S; Klatt C; Bayer JK; Waldheim JN; Rabausch B; Nagy N; Oberhuber A; Deenen R; Köhrer K; Lehr S; Homey B; Pfeffer K; Fischer JW
Circ Res; 2015 Apr; 116(8):e57-68. PubMed ID: 25740843
[TBL] [Abstract][Full Text] [Related]
5. Macrophage migration inhibitory factor deficiency impairs atherosclerosis in low-density lipoprotein receptor-deficient mice.
Pan JH; Sukhova GK; Yang JT; Wang B; Xie T; Fu H; Zhang Y; Satoskar AR; David JR; Metz CN; Bucala R; Fang K; Simon DI; Chapman HA; Libby P; Shi GP
Circulation; 2004 Jun; 109(25):3149-53. PubMed ID: 15197138
[TBL] [Abstract][Full Text] [Related]
6. Nuclear factor E2-related factor 2 deficiency impairs atherosclerotic lesion development but promotes features of plaque instability in hypercholesterolaemic mice.
Ruotsalainen AK; Lappalainen JP; Heiskanen E; Merentie M; Sihvola V; Näpänkangas J; Lottonen-Raikaslehto L; Kansanen E; Adinolfi S; Kaarniranta K; Ylä-Herttuala S; Jauhiainen M; Pirinen E; Levonen AL
Cardiovasc Res; 2019 Jan; 115(1):243-254. PubMed ID: 29917052
[TBL] [Abstract][Full Text] [Related]
7. Expression of human tissue factor pathway inhibitor on vascular smooth muscle cells inhibits secretion of macrophage migration inhibitory factor and attenuates atherosclerosis in ApoE-/- mice.
Chen D; Xia M; Hayford C; Tham el-L; Semik V; Hurst S; Chen Y; Tam HH; Pan J; Wang Y; Tan X; Lan HY; Shen H; Kakkar VV; Xu Q; McVey JH; Dorling A
Circulation; 2015 Apr; 131(15):1350-60. PubMed ID: 25677604
[TBL] [Abstract][Full Text] [Related]
8. High fat / high cholesterol diet does not provoke atherosclerosis in the ω3-and ω6-polyunsaturated fatty acid synthesis-inactivated Δ6-fatty acid desaturase-deficient mouse.
Stoffel W; Binczek E; Schmidt-Soltau I; Brodesser S; Wegner I
Mol Metab; 2021 Dec; 54():101335. PubMed ID: 34530175
[TBL] [Abstract][Full Text] [Related]
9. Hematopoietic ChemR23 (Chemerin Receptor 23) Fuels Atherosclerosis by Sustaining an M1 Macrophage-Phenotype and Guidance of Plasmacytoid Dendritic Cells to Murine Lesions-Brief Report.
van der Vorst EPC; Mandl M; Müller M; Neideck C; Jansen Y; Hristov M; Gencer S; Peters LJF; Meiler S; Feld M; Geiselhöringer AL; de Jong RJ; Ohnmacht C; Noels H; Soehnlein O; Drechsler M; Weber C; Döring Y
Arterioscler Thromb Vasc Biol; 2019 Apr; 39(4):685-693. PubMed ID: 30786742
[TBL] [Abstract][Full Text] [Related]
10. MIF-chemokine receptor interactions in atherogenesis are dependent on an N-loop-based 2-site binding mechanism.
Kraemer S; Lue H; Zernecke A; Kapurniotu A; Andreetto E; Frank R; Lennartz B; Weber C; Bernhagen J
FASEB J; 2011 Mar; 25(3):894-906. PubMed ID: 21106938
[TBL] [Abstract][Full Text] [Related]
11. Smooth Muscle Cell-Derived Interleukin-17C Plays an Atherogenic Role via the Recruitment of Proinflammatory Interleukin-17A+ T Cells to the Aorta.
Butcher MJ; Waseem TC; Galkina EV
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1496-506. PubMed ID: 27365405
[TBL] [Abstract][Full Text] [Related]
12. IgE Contributes to Atherosclerosis and Obesity by Affecting Macrophage Polarization, Macrophage Protein Network, and Foam Cell Formation.
Zhang X; Li J; Luo S; Wang M; Huang Q; Deng Z; de Febbo C; Daoui A; Liew PX; Sukhova GK; Metso J; Jauhiainen M; Shi GP; Guo J
Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):597-610. PubMed ID: 31996021
[TBL] [Abstract][Full Text] [Related]
13. Gremlin-1 is an inhibitor of macrophage migration inhibitory factor and attenuates atherosclerotic plaque growth in ApoE-/- Mice.
Müller I; Schönberger T; Schneider M; Borst O; Ziegler M; Seizer P; Leder C; Müller K; Lang M; Appenzeller F; Lunov O; Büchele B; Fahrleitner M; Olbrich M; Langer H; Geisler T; Lang F; Chatterjee M; de Boer JF; Tietge UJ; Bernhagen J; Simmet T; Gawaz M
J Biol Chem; 2013 Nov; 288(44):31635-45. PubMed ID: 24003215
[TBL] [Abstract][Full Text] [Related]
14. Macrophage Migration Inhibitory Factor (MIF)-Based Therapeutic Concepts in Atherosclerosis and Inflammation.
Sinitski D; Kontos C; Krammer C; Asare Y; Kapurniotu A; Bernhagen J
Thromb Haemost; 2019 Apr; 119(4):553-566. PubMed ID: 30716779
[TBL] [Abstract][Full Text] [Related]
15. Chemokine-like functions of MIF in atherosclerosis.
Schober A; Bernhagen J; Weber C
J Mol Med (Berl); 2008 Jul; 86(7):761-70. PubMed ID: 18385967
[TBL] [Abstract][Full Text] [Related]
16. Macrophage migration inhibitory factor and CD74 regulate macrophage chemotactic responses via MAPK and Rho GTPase.
Fan H; Hall P; Santos LL; Gregory JL; Fingerle-Rowson G; Bucala R; Morand EF; Hickey MJ
J Immunol; 2011 Apr; 186(8):4915-24. PubMed ID: 21411731
[TBL] [Abstract][Full Text] [Related]
17. Platelet-derived MIF: a novel platelet chemokine with distinct recruitment properties.
Wirtz TH; Tillmann S; Strüßmann T; Kraemer S; Heemskerk JW; Grottke O; Gawaz M; von Hundelshausen P; Bernhagen J
Atherosclerosis; 2015 Mar; 239(1):1-10. PubMed ID: 25561410
[TBL] [Abstract][Full Text] [Related]
18. Structural determinants of MIF functions in CXCR2-mediated inflammatory and atherogenic leukocyte recruitment.
Weber C; Kraemer S; Drechsler M; Lue H; Koenen RR; Kapurniotu A; Zernecke A; Bernhagen J
Proc Natl Acad Sci U S A; 2008 Oct; 105(42):16278-83. PubMed ID: 18852457
[TBL] [Abstract][Full Text] [Related]
19. MCS-18, a natural product isolated from Helleborus purpurascens, inhibits maturation of dendritic cells in ApoE-deficient mice and prevents early atherosclerosis progression.
Dietel B; Muench R; Kuehn C; Kerek F; Steinkasserer A; Achenbach S; Garlichs CD; Zinser E
Atherosclerosis; 2014 Aug; 235(2):263-72. PubMed ID: 24887015
[TBL] [Abstract][Full Text] [Related]
20. α4β7 Integrin (LPAM-1) is upregulated at atherosclerotic lesions and is involved in atherosclerosis progression.
Zhi K; Li M; Zhang X; Gao Z; Bai J; Wu Y; Zhou S; Li M; Qu L
Cell Physiol Biochem; 2014; 33(6):1876-87. PubMed ID: 24970009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
